Over a year into the COVID pandemic, there is a growing sentiment that the digital-first adaptations that began as patchwork have become ingrained into our
Artificial Intelligence (AI) is revolutionizing enterprise and consumer technology as we know it, but few industries have made strides as significant as healthcare and life
As Head of Sales at a global software company, I’ve been in the tech and sales industry for over 30 years. And while these traditionally
Due to a global pandemic and challenging economy, 2020 required a shift in how salespeople do their jobs and interact with customers. To adapt, many
With so many online marketing and sales channels, it can be difficult to determine which
Selling is tough; it is beyond handing over your product in exchange for some money.
In B2B sales and marketing, it is never a good idea to assume that your
Data privacy and protection is a crucial matter of concern today, and businesses have been
Sales automation enables sales teams to concentrate on critical activities by relieving them of administrative
Often times, B2B sales is considered challenging. But one of the greatest things in B2B
HydRx Wellness is pleased to announce a Strategic Research Partnership with Sadick Research Group to Pioneer Next-Generation Hair, Skin, and Longevity Products in the new and emerging field of TricoHealth. Concurrently, HydRx Wellness expands its global footprint with New U.S.
Immunophotonics, Inc., a clinical-stage biotech company focused on developing novel Immune-stimulating drugs to augment routine tumor destruction techniques, has announced the appointment of Richard Levenson, M.D. to its Board of Directors.Dr. Levenson further strengthens the company’s Board of Directors with
Cousins Matthew and Christopher Callero join Cetera to access expanded growth resources and support their expansion plans Cetera is pleased to announce that veteran advisors Matthew Callero, CRPC®, and Christopher Callero, CFP®, have joined Cetera Financial Specialists within Cetera’s Tax
Brought to you by
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.
